WP-1303 (worgpharma)

N/A

Report date: 2022/11/21 19:09:04

Base Information

Drug NameWP-1303 (worgpharma)
Drug Alias NameAntigen processing-independent epitopes - Apitope TechnologyAPI 1/4/6/7ATX-MS-1467ATX-MS-01MSC-2358825A +[7] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunomodulatorsT lymphocytes stimulantsInterleukin-10 stimulants +[4] 
TargetsMajor histocompatibility complex IIInterleukin-10
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple SclerosisMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian FederationGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesApitope Technology
China Registration ClassN/A

Develop Information

Active CompaniesWorg Pharmaceuticals (Hangzhou) Co Ltd
Inactive CompaniesApitope Technology (Bristol) LtdMerck KGaA, Darmstadt, Germany
Active IndicationsMultiple Myeloma
Inactive IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A